On July 7th, President Biden awarded Sister Simone Campbell the Presidential Medal of Freedom, the nation’s highest civilian honor. Campbell is executive director of a national Catholic social justice advocacy organization. She represents a longstandin…
Brexafemme is a recently approved drug for vaginal yeast infection; the first non-azole treatment. The drug’s sponsor, Scynexis, has made progress in the commercial market, facilitating access. But payer pricing and reimbursement challenges remain.
The Supreme Court’s decision in the West Virginia v EPA case has repercussions that extend beyond the EPA’s ability to regulate the environment. The decision could in fact impact the authority of all federal agencies that issue regulations, such as the…
Last month, the FTC voted unanimously to examine rising list prices of insulin, but also to probe possible anti-competitive practices by PBMs. Proof of the establishment of anti-competitive practices – such as rebate walls – would likely lead to legal …
Senate Democrats appear to be making progress on pushing forward a set of politically popular drug pricing reforms. A detailed plan has yet to be released. However, reports suggest the plan would be similar to provisions included in Build Back Better l…
The Dutch Center for Infectious Disease Control (RIVM) released interim results on Tuesday, June 21st, which show that approximately 50% of patients enrolled in a large ongoing study still have one or more symptoms three months after becoming infected …
Both the FTC and Congress want to rein in pharmacy benefit managers (PBMs), as they focus on alleged anti-competitive practices which hinder a properly functioning prescription drug market. Maybe this time an inquiry and legislative action will happen,…
While a large Build Back Better bill was scuttled last winter, a substantially slimmed down version may still pass. And, this piece of legislation could contain prescription drug pricing stipulations designed to decrease government spending on pharmace…
While until now no state has banned medication abortions, Oklahoma’s GOP governor Kevin Stitt will soon sign legislation outlawing all abortions from the moment of “fertilization.” Presumably, this would include a prohibition of the use of mifepristone…
Pfizer’s recent announcement regarding sales of its branded products on a not-for-profit – at cost – basis to low- and lower-middle-jncome countries may prove to be a real game-changer in global health, particularly if other companies follow suit.